Status:
COMPLETED
Intramuscular Ketamine Effect on Postnasal Surgery Agitation
Lead Sponsor:
Jordanian Royal Medical Services
Conditions:
Agitation, Emergence
Eligibility:
All Genders
18-64 years
Phase:
PHASE2
Brief Summary
Emergence agitation (EA) is a common complication after nasal surgery. In this study, we aimed to investigate the effect of intramuscular ketamine on EA following septoplasty and open septorhinoplasty...
Detailed Description
At the end of surgery and immediately after the inhalational agent was discontinued, 2mL of normal saline containing 0.7 mg/kg racemic ketamine was administered intramuscularly to Group-K, whereas 2 m...
Eligibility Criteria
Inclusion
- Age group 18-64 years old
- ASA I-II
- BMI 20-29.9
- Patients accepting the study and consenting
- Undergoing general anesthesia for scheduled septoplasty or open septorhinoplasty.
Exclusion
- ketamine allergy
- Morphine allergy
- History of cardiac, neurological, or psychiatric disease, glaucoma,
- Patients with a body mass index of less than 20 or more than 30 kg/m2
Key Trial Info
Start Date :
May 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2022
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT05313659
Start Date
May 11 2022
End Date
October 20 2022
Last Update
January 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jordanian Royal Medical Services
Amman, Jordan, 11855